SlideShare a Scribd company logo
1 of 13
Download to read offline
How to understand
regulators to design
experiments in pharma
product development
Ajaz | Insights
DOE why?
Rational, rigorous, reproducible and repeatable
cause-and-effect relationships that serve as
evidence and warrant your claims
Critical quality attributes, critical process parameters,
speculations, stability (shelf-life), repeatability, reproducibility,
… bioavailability, bioequivalence
And Design Space, Comparability Protocol, Evolutionary Operation
(EVOP), Continual Improvement
Compared to “one factor at a time” experiments, increased experimental efficiency, accounting
interactions, multivariate predictive capability, minimization, maximization, optimization, graphical
illustration for enhanced communication of complex topics
Design of Experiments:
In developing products
and their manufacturing
process
DOE is not Design Space
4/22/2021 Ajaz S Hussain Ph.D. 7
Design Space(ICH Q8R2): Misconceptions
• DOE = Design Space
• Design Space is required
• Including of Design Space in development report will reduce
deficiencies
• Only critical parameters should be in a Design Space
• Edge-of-failure needed to define Design Space
Take an
integrated
design and
systems
approach
Ask the right questions to know the answers you want
Then design your experiments – not just jump to a
popular design
Consider real-world constraints; e.g., mixture designs
Remember garbage in = garbage out
DOE “Good Practices,” e.g., randomization,
replication,…. Assumptions, constraints
The approach you take to DOE says a lot about your
“development”
Pharmaceutical Quality System
4/22/2021 Ajaz S Hussain Ph.D. 10
Design thinking
Inspiration, ideation, and implementation
Desirability
“voice of the customer,” human-centered design or empathy,
to fully understand the problems within the organization by
asking what people are “hearing and seeing and feeling and
thinking.”
Feasibility what is possible in the organization in terms of existing and
potential capacity, human resources, processes, and technology
Viability
how an initiative can be “hardwired into the organization” so it
has a higher likelihood of continuing long past the point of
implementation – over a product life cycle
Integrative
Thinking
• Salient variables are identified, the
causal map is built, action is
sequenced, and choices made
• P-centric design; P = profiteer, patient,
public-health, professionals &
practitioners
• Regulatory life-cycle system
• Mechanistic & statistical predictability
Roger Martin and Hilary Austen. The Art of Integrative Thinking.
Rotman Management Fall 1999
By Design is intention to do good
not just be and look good.
Do + Be + Look Good is
integrated development
Do good is to be self-authored,
self-assured, internally validated
Be good is to comply to what
others require
Looking good seeks external
validation

More Related Content

What's hot

NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 FinalNIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 FinalAjaz Hussain
 
Visioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA CollaborationVisioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA CollaborationAjaz Hussain
 
Product Quality & Patient Safety USP Workshop Mumbai 12 June 2015
Product Quality & Patient Safety USP Workshop Mumbai 12 June 2015Product Quality & Patient Safety USP Workshop Mumbai 12 June 2015
Product Quality & Patient Safety USP Workshop Mumbai 12 June 2015Ajaz Hussain
 
Totality of Evidence & Theraputic Equivalence 15 October 2016
Totality of Evidence & Theraputic Equivalence 15 October 2016Totality of Evidence & Theraputic Equivalence 15 October 2016
Totality of Evidence & Theraputic Equivalence 15 October 2016Ajaz Hussain
 
Behavioral Economics and Managment of Pharmaceutical QbD 25 August 2016
Behavioral Economics and Managment of Pharmaceutical QbD 25 August 2016Behavioral Economics and Managment of Pharmaceutical QbD 25 August 2016
Behavioral Economics and Managment of Pharmaceutical QbD 25 August 2016Ajaz Hussain
 
CHIR Best Brains Exchange 22 January 2016
CHIR Best Brains Exchange 22 January 2016CHIR Best Brains Exchange 22 January 2016
CHIR Best Brains Exchange 22 January 2016Ajaz Hussain
 
Managing Pharmaceutical Quality in Traditional Paradigm and in the Emerging “...
Managing Pharmaceutical Quality in Traditional Paradigm and in the Emerging “...Managing Pharmaceutical Quality in Traditional Paradigm and in the Emerging “...
Managing Pharmaceutical Quality in Traditional Paradigm and in the Emerging “...Ajaz Hussain
 
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...Ajaz Hussain
 
QbR to QbD to CPV 16 February 2015
QbR to QbD to CPV 16 February 2015QbR to QbD to CPV 16 February 2015
QbR to QbD to CPV 16 February 2015Ajaz Hussain
 
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016 Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016 Ajaz Hussain
 
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences minIGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences minAjaz Hussain
 
NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017Ajaz Hussain
 
Meaning making measurement maturity and management moksha
Meaning making measurement maturity and management mokshaMeaning making measurement maturity and management moksha
Meaning making measurement maturity and management mokshaAjaz Hussain
 
Excipients knowledge management IFPAC 2016
Excipients knowledge management IFPAC 2016Excipients knowledge management IFPAC 2016
Excipients knowledge management IFPAC 2016Ajaz Hussain
 
FDA Trend: New Validation Strategies
FDA Trend: New Validation StrategiesFDA Trend: New Validation Strategies
FDA Trend: New Validation StrategiesAjaz Hussain
 
Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...
Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...
Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...Ajaz Hussain
 
Compliance in the Age of Lockdowns & Disruptions: Reconciling Different Persp...
Compliance in the Age of Lockdowns & Disruptions: Reconciling Different Persp...Compliance in the Age of Lockdowns & Disruptions: Reconciling Different Persp...
Compliance in the Age of Lockdowns & Disruptions: Reconciling Different Persp...Ajaz Hussain
 
Strengthening the National System for Excipient Risk Mitigation
Strengthening the National System for Excipient Risk Mitigation Strengthening the National System for Excipient Risk Mitigation
Strengthening the National System for Excipient Risk Mitigation Ajaz Hussain
 
Dr Venkateswarlu Memorial Lecture 2015
Dr Venkateswarlu Memorial Lecture 2015Dr Venkateswarlu Memorial Lecture 2015
Dr Venkateswarlu Memorial Lecture 2015Ajaz Hussain
 

What's hot (20)

NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 FinalNIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
NIPTE Conference 2016 Keynote Ajaz Hussain 09272016 Final
 
Visioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA CollaborationVisioning the Next Decade: NIPTE-FDA Collaboration
Visioning the Next Decade: NIPTE-FDA Collaboration
 
Product Quality & Patient Safety USP Workshop Mumbai 12 June 2015
Product Quality & Patient Safety USP Workshop Mumbai 12 June 2015Product Quality & Patient Safety USP Workshop Mumbai 12 June 2015
Product Quality & Patient Safety USP Workshop Mumbai 12 June 2015
 
Totality of Evidence & Theraputic Equivalence 15 October 2016
Totality of Evidence & Theraputic Equivalence 15 October 2016Totality of Evidence & Theraputic Equivalence 15 October 2016
Totality of Evidence & Theraputic Equivalence 15 October 2016
 
Behavioral Economics and Managment of Pharmaceutical QbD 25 August 2016
Behavioral Economics and Managment of Pharmaceutical QbD 25 August 2016Behavioral Economics and Managment of Pharmaceutical QbD 25 August 2016
Behavioral Economics and Managment of Pharmaceutical QbD 25 August 2016
 
CHIR Best Brains Exchange 22 January 2016
CHIR Best Brains Exchange 22 January 2016CHIR Best Brains Exchange 22 January 2016
CHIR Best Brains Exchange 22 January 2016
 
Managing Pharmaceutical Quality in Traditional Paradigm and in the Emerging “...
Managing Pharmaceutical Quality in Traditional Paradigm and in the Emerging “...Managing Pharmaceutical Quality in Traditional Paradigm and in the Emerging “...
Managing Pharmaceutical Quality in Traditional Paradigm and in the Emerging “...
 
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
 
QbR to QbD to CPV 16 February 2015
QbR to QbD to CPV 16 February 2015QbR to QbD to CPV 16 February 2015
QbR to QbD to CPV 16 February 2015
 
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016 Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016
Pharmaceutical Quality by Design Travel Options Keynote @ Patheon QbD 2016
 
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences minIGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
 
NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017NIPTE Roadmap 2017 Discussion @ IFPAC 2017
NIPTE Roadmap 2017 Discussion @ IFPAC 2017
 
Meaning making measurement maturity and management moksha
Meaning making measurement maturity and management mokshaMeaning making measurement maturity and management moksha
Meaning making measurement maturity and management moksha
 
Excipients knowledge management IFPAC 2016
Excipients knowledge management IFPAC 2016Excipients knowledge management IFPAC 2016
Excipients knowledge management IFPAC 2016
 
FDA Trend: New Validation Strategies
FDA Trend: New Validation StrategiesFDA Trend: New Validation Strategies
FDA Trend: New Validation Strategies
 
Pharmaceuticals Dashboard 2021
Pharmaceuticals Dashboard 2021Pharmaceuticals Dashboard 2021
Pharmaceuticals Dashboard 2021
 
Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...
Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...
Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...
 
Compliance in the Age of Lockdowns & Disruptions: Reconciling Different Persp...
Compliance in the Age of Lockdowns & Disruptions: Reconciling Different Persp...Compliance in the Age of Lockdowns & Disruptions: Reconciling Different Persp...
Compliance in the Age of Lockdowns & Disruptions: Reconciling Different Persp...
 
Strengthening the National System for Excipient Risk Mitigation
Strengthening the National System for Excipient Risk Mitigation Strengthening the National System for Excipient Risk Mitigation
Strengthening the National System for Excipient Risk Mitigation
 
Dr Venkateswarlu Memorial Lecture 2015
Dr Venkateswarlu Memorial Lecture 2015Dr Venkateswarlu Memorial Lecture 2015
Dr Venkateswarlu Memorial Lecture 2015
 

Similar to Design is to do good not just be and look good: Bad Design is Smoke, Good Design is a Mirror.

Process Excellence TQM
Process Excellence TQMProcess Excellence TQM
Process Excellence TQMMahzad Pakzad
 
Design Thinking: 5 Steps to Healthy Healthcare Apps
Design Thinking: 5 Steps to Healthy Healthcare AppsDesign Thinking: 5 Steps to Healthy Healthcare Apps
Design Thinking: 5 Steps to Healthy Healthcare AppsJeffery Belden
 
Evidence Based Wellness (Helping Human Resources Shop Better)
Evidence Based Wellness (Helping Human Resources Shop Better)Evidence Based Wellness (Helping Human Resources Shop Better)
Evidence Based Wellness (Helping Human Resources Shop Better)Joel Bennett
 
How to close CS/engineering doctor divide.pptx
How to close CS/engineering doctor divide.pptxHow to close CS/engineering doctor divide.pptx
How to close CS/engineering doctor divide.pptxArlen Meyers, MD, MBA
 
HXD 2019 Leadership Round Table
HXD 2019 Leadership Round TableHXD 2019 Leadership Round Table
HXD 2019 Leadership Round TableMad*Pow
 
WhitepaperMedicalSystems
WhitepaperMedicalSystemsWhitepaperMedicalSystems
WhitepaperMedicalSystemsJohnsrud
 
Day 1 revision
Day 1  revisionDay 1  revision
Day 1 revisionJoyce Wong
 
ONE POINT OF VIEWPaul N. Friga and Richard B. ChapasMA.docx
ONE POINT OF VIEWPaul N. Friga and Richard B. ChapasMA.docxONE POINT OF VIEWPaul N. Friga and Richard B. ChapasMA.docx
ONE POINT OF VIEWPaul N. Friga and Richard B. ChapasMA.docxhopeaustin33688
 
Pharmaceutical Quality by Design: Review of Progress and Challenges
Pharmaceutical Quality by Design: Review of Progress and ChallengesPharmaceutical Quality by Design: Review of Progress and Challenges
Pharmaceutical Quality by Design: Review of Progress and ChallengesAjaz Hussain
 
[Case Study] Physician, Know Thy User: Using Personas to Target Content and U...
[Case Study] Physician, Know Thy User: Using Personas to Target Content and U...[Case Study] Physician, Know Thy User: Using Personas to Target Content and U...
[Case Study] Physician, Know Thy User: Using Personas to Target Content and U...Scott Abel
 
Physician Know Thy Customers
Physician Know Thy CustomersPhysician Know Thy Customers
Physician Know Thy Customerssundong
 
Effectiveness Through Strategy And Organizational Design
Effectiveness Through Strategy And Organizational Design Effectiveness Through Strategy And Organizational Design
Effectiveness Through Strategy And Organizational Design Seta Wicaksana
 
The Power of HR Analytics
The Power of HR AnalyticsThe Power of HR Analytics
The Power of HR AnalyticsHackerEarth
 
Pharmaceutical culture of quality
Pharmaceutical culture of qualityPharmaceutical culture of quality
Pharmaceutical culture of qualityAjaz Hussain
 
290611 strategy defined, explained and problematized
290611 strategy defined, explained and problematized290611 strategy defined, explained and problematized
290611 strategy defined, explained and problematizedAnders Birch
 
HIMSS Innovation Pathways Summary
HIMSS Innovation Pathways SummaryHIMSS Innovation Pathways Summary
HIMSS Innovation Pathways SummaryEd Dodds
 
Jeff davis top coder 12 3 2012 final
Jeff davis top coder 12 3 2012 finalJeff davis top coder 12 3 2012 final
Jeff davis top coder 12 3 2012 finalwww_TopCoder_com
 
Implementation of an Evaluation Model for Evaluating Complex Health Research ...
Implementation of an Evaluation Model for Evaluating Complex Health Research ...Implementation of an Evaluation Model for Evaluating Complex Health Research ...
Implementation of an Evaluation Model for Evaluating Complex Health Research ...aihs
 

Similar to Design is to do good not just be and look good: Bad Design is Smoke, Good Design is a Mirror. (20)

Process Excellence TQM
Process Excellence TQMProcess Excellence TQM
Process Excellence TQM
 
Design Thinking: 5 Steps to Healthy Healthcare Apps
Design Thinking: 5 Steps to Healthy Healthcare AppsDesign Thinking: 5 Steps to Healthy Healthcare Apps
Design Thinking: 5 Steps to Healthy Healthcare Apps
 
Evidence Based Wellness (Helping Human Resources Shop Better)
Evidence Based Wellness (Helping Human Resources Shop Better)Evidence Based Wellness (Helping Human Resources Shop Better)
Evidence Based Wellness (Helping Human Resources Shop Better)
 
How to close CS/engineering doctor divide.pptx
How to close CS/engineering doctor divide.pptxHow to close CS/engineering doctor divide.pptx
How to close CS/engineering doctor divide.pptx
 
HXD 2019 Leadership Round Table
HXD 2019 Leadership Round TableHXD 2019 Leadership Round Table
HXD 2019 Leadership Round Table
 
WhitepaperMedicalSystems
WhitepaperMedicalSystemsWhitepaperMedicalSystems
WhitepaperMedicalSystems
 
Day 1 revision
Day 1  revisionDay 1  revision
Day 1 revision
 
ONE POINT OF VIEWPaul N. Friga and Richard B. ChapasMA.docx
ONE POINT OF VIEWPaul N. Friga and Richard B. ChapasMA.docxONE POINT OF VIEWPaul N. Friga and Richard B. ChapasMA.docx
ONE POINT OF VIEWPaul N. Friga and Richard B. ChapasMA.docx
 
Pharmaceutical Quality by Design: Review of Progress and Challenges
Pharmaceutical Quality by Design: Review of Progress and ChallengesPharmaceutical Quality by Design: Review of Progress and Challenges
Pharmaceutical Quality by Design: Review of Progress and Challenges
 
[Case Study] Physician, Know Thy User: Using Personas to Target Content and U...
[Case Study] Physician, Know Thy User: Using Personas to Target Content and U...[Case Study] Physician, Know Thy User: Using Personas to Target Content and U...
[Case Study] Physician, Know Thy User: Using Personas to Target Content and U...
 
Physician Know Thy Customers
Physician Know Thy CustomersPhysician Know Thy Customers
Physician Know Thy Customers
 
Effectiveness Through Strategy And Organizational Design
Effectiveness Through Strategy And Organizational Design Effectiveness Through Strategy And Organizational Design
Effectiveness Through Strategy And Organizational Design
 
The Power of HR Analytics
The Power of HR AnalyticsThe Power of HR Analytics
The Power of HR Analytics
 
Pharmaceutical culture of quality
Pharmaceutical culture of qualityPharmaceutical culture of quality
Pharmaceutical culture of quality
 
Human factors and ergonomics update
Human factors and ergonomics updateHuman factors and ergonomics update
Human factors and ergonomics update
 
290611 strategy defined, explained and problematized
290611 strategy defined, explained and problematized290611 strategy defined, explained and problematized
290611 strategy defined, explained and problematized
 
HIMSS Innovation Pathways Summary
HIMSS Innovation Pathways SummaryHIMSS Innovation Pathways Summary
HIMSS Innovation Pathways Summary
 
Jeff davis top coder 12 3 2012 final
Jeff davis top coder 12 3 2012 finalJeff davis top coder 12 3 2012 final
Jeff davis top coder 12 3 2012 final
 
Implementation of an Evaluation Model for Evaluating Complex Health Research ...
Implementation of an Evaluation Model for Evaluating Complex Health Research ...Implementation of an Evaluation Model for Evaluating Complex Health Research ...
Implementation of an Evaluation Model for Evaluating Complex Health Research ...
 
Organisation development
Organisation developmentOrganisation development
Organisation development
 

More from Ajaz Hussain

A Leapfrog Need and Opportunity for mAbs
A Leapfrog Need and Opportunity for mAbsA Leapfrog Need and Opportunity for mAbs
A Leapfrog Need and Opportunity for mAbsAjaz Hussain
 
SMART Quality by Design Applications Not Submissions in 2024
SMART Quality by Design Applications Not Submissions in 2024SMART Quality by Design Applications Not Submissions in 2024
SMART Quality by Design Applications Not Submissions in 2024Ajaz Hussain
 
Intuitively Moving Institutions Towards Global Regulatory Resilience
Intuitively Moving Institutions Towards Global Regulatory Resilience Intuitively Moving Institutions Towards Global Regulatory Resilience
Intuitively Moving Institutions Towards Global Regulatory Resilience Ajaz Hussain
 
Critical Importance of Pharmaceutical Traceability in the Experience.pdf
Critical Importance of Pharmaceutical Traceability in the Experience.pdfCritical Importance of Pharmaceutical Traceability in the Experience.pdf
Critical Importance of Pharmaceutical Traceability in the Experience.pdfAjaz Hussain
 
Validation 4 for Credible Pharma 4 a Keynote for Valconnect 2023.pdf
Validation 4 for Credible Pharma 4 a Keynote for  Valconnect 2023.pdfValidation 4 for Credible Pharma 4 a Keynote for  Valconnect 2023.pdf
Validation 4 for Credible Pharma 4 a Keynote for Valconnect 2023.pdfAjaz Hussain
 
SMART Triaxial Compaction, Social Form 483 and VAI or OAI to an Avenger.pdf
SMART Triaxial Compaction, Social Form 483 and VAI or OAI to an Avenger.pdfSMART Triaxial Compaction, Social Form 483 and VAI or OAI to an Avenger.pdf
SMART Triaxial Compaction, Social Form 483 and VAI or OAI to an Avenger.pdfAjaz Hussain
 
Statistical Thinking and Pharmaceutical Professional Development, a keynote b...
Statistical Thinking and Pharmaceutical Professional Development, a keynote b...Statistical Thinking and Pharmaceutical Professional Development, a keynote b...
Statistical Thinking and Pharmaceutical Professional Development, a keynote b...Ajaz Hussain
 
An Updating Perspective on BAD I in March Madness 2023.pdf
An Updating Perspective on BAD I in March Madness 2023.pdfAn Updating Perspective on BAD I in March Madness 2023.pdf
An Updating Perspective on BAD I in March Madness 2023.pdfAjaz Hussain
 
Mature Managers and Management of Pharmaceutical Quality and Quantities
Mature Managers and Management of Pharmaceutical Quality and QuantitiesMature Managers and Management of Pharmaceutical Quality and Quantities
Mature Managers and Management of Pharmaceutical Quality and QuantitiesAjaz Hussain
 
I-SMART Internal Validation for Continuous Professional Development.pdf
I-SMART Internal Validation for Continuous Professional Development.pdfI-SMART Internal Validation for Continuous Professional Development.pdf
I-SMART Internal Validation for Continuous Professional Development.pdfAjaz Hussain
 
S.M.A.R.T Pharmaceuticals 2021 -2030: AI or Human?
S.M.A.R.T Pharmaceuticals 2021 -2030: AI or Human?S.M.A.R.T Pharmaceuticals 2021 -2030: AI or Human?
S.M.A.R.T Pharmaceuticals 2021 -2030: AI or Human?Ajaz Hussain
 
Between Hello and Goodbye is Qualia: AICTE Faculty Development Program 29 M...
Between Hello and Goodbye is Qualia:  AICTE  Faculty Development Program 29 M...Between Hello and Goodbye is Qualia:  AICTE  Faculty Development Program 29 M...
Between Hello and Goodbye is Qualia: AICTE Faculty Development Program 29 M...Ajaz Hussain
 
Pharmaceutical Quality in the 21st Century, Current Status of PAT & QbD
Pharmaceutical Quality in the 21st Century, Current Status of PAT & QbDPharmaceutical Quality in the 21st Century, Current Status of PAT & QbD
Pharmaceutical Quality in the 21st Century, Current Status of PAT & QbDAjaz Hussain
 
Professionals and human experience: Ex[CI]perience Lessons in Excipients
Professionals and human experience: Ex[CI]perience Lessons in Excipients Professionals and human experience: Ex[CI]perience Lessons in Excipients
Professionals and human experience: Ex[CI]perience Lessons in Excipients Ajaz Hussain
 
Industrial Policy and NIPTE: Goodbye NIPTE
Industrial Policy and NIPTE: Goodbye NIPTE Industrial Policy and NIPTE: Goodbye NIPTE
Industrial Policy and NIPTE: Goodbye NIPTE Ajaz Hussain
 
Uncertainty Management: Chaos to Continual Improvement
Uncertainty Management: Chaos to Continual ImprovementUncertainty Management: Chaos to Continual Improvement
Uncertainty Management: Chaos to Continual ImprovementAjaz Hussain
 
Ajaz 2020 insights on What Next for Quality of Pharmaceuticals
Ajaz 2020 insights on What Next for Quality of PharmaceuticalsAjaz 2020 insights on What Next for Quality of Pharmaceuticals
Ajaz 2020 insights on What Next for Quality of PharmaceuticalsAjaz Hussain
 
How to Prepare for the New World of Pharmaceutical Development and Manufactu...
How to Prepare for the New World of Pharmaceutical Development and  Manufactu...How to Prepare for the New World of Pharmaceutical Development and  Manufactu...
How to Prepare for the New World of Pharmaceutical Development and Manufactu...Ajaz Hussain
 
Knowledge, Risk and Satisfaction Management 21 Century Pharmaceuticals, Octo...
Knowledge,  Risk and Satisfaction Management 21 Century Pharmaceuticals, Octo...Knowledge,  Risk and Satisfaction Management 21 Century Pharmaceuticals, Octo...
Knowledge, Risk and Satisfaction Management 21 Century Pharmaceuticals, Octo...Ajaz Hussain
 
Leadership for the 21st Century Pharmaceuticals @ University of Lisbon Octob...
Leadership for the  21st Century Pharmaceuticals @ University of Lisbon Octob...Leadership for the  21st Century Pharmaceuticals @ University of Lisbon Octob...
Leadership for the 21st Century Pharmaceuticals @ University of Lisbon Octob...Ajaz Hussain
 

More from Ajaz Hussain (20)

A Leapfrog Need and Opportunity for mAbs
A Leapfrog Need and Opportunity for mAbsA Leapfrog Need and Opportunity for mAbs
A Leapfrog Need and Opportunity for mAbs
 
SMART Quality by Design Applications Not Submissions in 2024
SMART Quality by Design Applications Not Submissions in 2024SMART Quality by Design Applications Not Submissions in 2024
SMART Quality by Design Applications Not Submissions in 2024
 
Intuitively Moving Institutions Towards Global Regulatory Resilience
Intuitively Moving Institutions Towards Global Regulatory Resilience Intuitively Moving Institutions Towards Global Regulatory Resilience
Intuitively Moving Institutions Towards Global Regulatory Resilience
 
Critical Importance of Pharmaceutical Traceability in the Experience.pdf
Critical Importance of Pharmaceutical Traceability in the Experience.pdfCritical Importance of Pharmaceutical Traceability in the Experience.pdf
Critical Importance of Pharmaceutical Traceability in the Experience.pdf
 
Validation 4 for Credible Pharma 4 a Keynote for Valconnect 2023.pdf
Validation 4 for Credible Pharma 4 a Keynote for  Valconnect 2023.pdfValidation 4 for Credible Pharma 4 a Keynote for  Valconnect 2023.pdf
Validation 4 for Credible Pharma 4 a Keynote for Valconnect 2023.pdf
 
SMART Triaxial Compaction, Social Form 483 and VAI or OAI to an Avenger.pdf
SMART Triaxial Compaction, Social Form 483 and VAI or OAI to an Avenger.pdfSMART Triaxial Compaction, Social Form 483 and VAI or OAI to an Avenger.pdf
SMART Triaxial Compaction, Social Form 483 and VAI or OAI to an Avenger.pdf
 
Statistical Thinking and Pharmaceutical Professional Development, a keynote b...
Statistical Thinking and Pharmaceutical Professional Development, a keynote b...Statistical Thinking and Pharmaceutical Professional Development, a keynote b...
Statistical Thinking and Pharmaceutical Professional Development, a keynote b...
 
An Updating Perspective on BAD I in March Madness 2023.pdf
An Updating Perspective on BAD I in March Madness 2023.pdfAn Updating Perspective on BAD I in March Madness 2023.pdf
An Updating Perspective on BAD I in March Madness 2023.pdf
 
Mature Managers and Management of Pharmaceutical Quality and Quantities
Mature Managers and Management of Pharmaceutical Quality and QuantitiesMature Managers and Management of Pharmaceutical Quality and Quantities
Mature Managers and Management of Pharmaceutical Quality and Quantities
 
I-SMART Internal Validation for Continuous Professional Development.pdf
I-SMART Internal Validation for Continuous Professional Development.pdfI-SMART Internal Validation for Continuous Professional Development.pdf
I-SMART Internal Validation for Continuous Professional Development.pdf
 
S.M.A.R.T Pharmaceuticals 2021 -2030: AI or Human?
S.M.A.R.T Pharmaceuticals 2021 -2030: AI or Human?S.M.A.R.T Pharmaceuticals 2021 -2030: AI or Human?
S.M.A.R.T Pharmaceuticals 2021 -2030: AI or Human?
 
Between Hello and Goodbye is Qualia: AICTE Faculty Development Program 29 M...
Between Hello and Goodbye is Qualia:  AICTE  Faculty Development Program 29 M...Between Hello and Goodbye is Qualia:  AICTE  Faculty Development Program 29 M...
Between Hello and Goodbye is Qualia: AICTE Faculty Development Program 29 M...
 
Pharmaceutical Quality in the 21st Century, Current Status of PAT & QbD
Pharmaceutical Quality in the 21st Century, Current Status of PAT & QbDPharmaceutical Quality in the 21st Century, Current Status of PAT & QbD
Pharmaceutical Quality in the 21st Century, Current Status of PAT & QbD
 
Professionals and human experience: Ex[CI]perience Lessons in Excipients
Professionals and human experience: Ex[CI]perience Lessons in Excipients Professionals and human experience: Ex[CI]perience Lessons in Excipients
Professionals and human experience: Ex[CI]perience Lessons in Excipients
 
Industrial Policy and NIPTE: Goodbye NIPTE
Industrial Policy and NIPTE: Goodbye NIPTE Industrial Policy and NIPTE: Goodbye NIPTE
Industrial Policy and NIPTE: Goodbye NIPTE
 
Uncertainty Management: Chaos to Continual Improvement
Uncertainty Management: Chaos to Continual ImprovementUncertainty Management: Chaos to Continual Improvement
Uncertainty Management: Chaos to Continual Improvement
 
Ajaz 2020 insights on What Next for Quality of Pharmaceuticals
Ajaz 2020 insights on What Next for Quality of PharmaceuticalsAjaz 2020 insights on What Next for Quality of Pharmaceuticals
Ajaz 2020 insights on What Next for Quality of Pharmaceuticals
 
How to Prepare for the New World of Pharmaceutical Development and Manufactu...
How to Prepare for the New World of Pharmaceutical Development and  Manufactu...How to Prepare for the New World of Pharmaceutical Development and  Manufactu...
How to Prepare for the New World of Pharmaceutical Development and Manufactu...
 
Knowledge, Risk and Satisfaction Management 21 Century Pharmaceuticals, Octo...
Knowledge,  Risk and Satisfaction Management 21 Century Pharmaceuticals, Octo...Knowledge,  Risk and Satisfaction Management 21 Century Pharmaceuticals, Octo...
Knowledge, Risk and Satisfaction Management 21 Century Pharmaceuticals, Octo...
 
Leadership for the 21st Century Pharmaceuticals @ University of Lisbon Octob...
Leadership for the  21st Century Pharmaceuticals @ University of Lisbon Octob...Leadership for the  21st Century Pharmaceuticals @ University of Lisbon Octob...
Leadership for the 21st Century Pharmaceuticals @ University of Lisbon Octob...
 

Recently uploaded

Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationRosabel UA
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptxmary850239
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management SystemChristalin Nelson
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management systemChristalin Nelson
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptxmary850239
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxlancelewisportillo
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptshraddhaparab530
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)cama23
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 

Recently uploaded (20)

Activity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translationActivity 2-unit 2-update 2024. English translation
Activity 2-unit 2-update 2024. English translation
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx4.18.24 Movement Legacies, Reflection, and Review.pptx
4.18.24 Movement Legacies, Reflection, and Review.pptx
 
Transaction Management in Database Management System
Transaction Management in Database Management SystemTransaction Management in Database Management System
Transaction Management in Database Management System
 
Concurrency Control in Database Management system
Concurrency Control in Database Management systemConcurrency Control in Database Management system
Concurrency Control in Database Management system
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptxYOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
YOUVE GOT EMAIL_FINALS_EL_DORADO_2024.pptx
 
4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx4.16.24 Poverty and Precarity--Desmond.pptx
4.16.24 Poverty and Precarity--Desmond.pptx
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptxQ4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
Q4-PPT-Music9_Lesson-1-Romantic-Opera.pptx
 
ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
Integumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.pptIntegumentary System SMP B. Pharm Sem I.ppt
Integumentary System SMP B. Pharm Sem I.ppt
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 

Design is to do good not just be and look good: Bad Design is Smoke, Good Design is a Mirror.

  • 1. How to understand regulators to design experiments in pharma product development Ajaz | Insights
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. DOE why? Rational, rigorous, reproducible and repeatable cause-and-effect relationships that serve as evidence and warrant your claims Critical quality attributes, critical process parameters, speculations, stability (shelf-life), repeatability, reproducibility, … bioavailability, bioequivalence And Design Space, Comparability Protocol, Evolutionary Operation (EVOP), Continual Improvement Compared to “one factor at a time” experiments, increased experimental efficiency, accounting interactions, multivariate predictive capability, minimization, maximization, optimization, graphical illustration for enhanced communication of complex topics
  • 7. Design of Experiments: In developing products and their manufacturing process DOE is not Design Space 4/22/2021 Ajaz S Hussain Ph.D. 7
  • 8. Design Space(ICH Q8R2): Misconceptions • DOE = Design Space • Design Space is required • Including of Design Space in development report will reduce deficiencies • Only critical parameters should be in a Design Space • Edge-of-failure needed to define Design Space
  • 9. Take an integrated design and systems approach Ask the right questions to know the answers you want Then design your experiments – not just jump to a popular design Consider real-world constraints; e.g., mixture designs Remember garbage in = garbage out DOE “Good Practices,” e.g., randomization, replication,…. Assumptions, constraints The approach you take to DOE says a lot about your “development”
  • 10. Pharmaceutical Quality System 4/22/2021 Ajaz S Hussain Ph.D. 10
  • 11. Design thinking Inspiration, ideation, and implementation Desirability “voice of the customer,” human-centered design or empathy, to fully understand the problems within the organization by asking what people are “hearing and seeing and feeling and thinking.” Feasibility what is possible in the organization in terms of existing and potential capacity, human resources, processes, and technology Viability how an initiative can be “hardwired into the organization” so it has a higher likelihood of continuing long past the point of implementation – over a product life cycle
  • 12. Integrative Thinking • Salient variables are identified, the causal map is built, action is sequenced, and choices made • P-centric design; P = profiteer, patient, public-health, professionals & practitioners • Regulatory life-cycle system • Mechanistic & statistical predictability Roger Martin and Hilary Austen. The Art of Integrative Thinking. Rotman Management Fall 1999
  • 13. By Design is intention to do good not just be and look good. Do + Be + Look Good is integrated development Do good is to be self-authored, self-assured, internally validated Be good is to comply to what others require Looking good seeks external validation